Introduction: Studies that investigated the relationship between fasting blood glucose (FBG) and intracerebral hemorrhage (ICH) outcomes were insufficient. Aim: We aimed to investigate the association between FBG level and in-hospital clinical outcomes in patients with primary ICH. Results: A total of 34,507 patients were enrolled in the final study. Compared with the reference group, the ≥6.1 and <7 mmol/L group showed nonsignificant higher in-hospital mortality (adjusted odds ratio [OR] 1.20, 95% confidence interval [CI] 0.69–2.11, p = 0.52), and a significant higher proportion of intracranial hematoma evacuation (adjusted OR 1.56, 95% CI 1.26–1.92, p < 0.001). The ≥7 mmol/L group showed both significant higher in-hospital mortality (adjusted OR 2.08, 95% CI 1.42–3.04, p = 0.52) and a significant higher proportion of intracranial hematoma evacuation (adjusted OR 2.09, 95% CI 1.78–2.47, p < 0.001). Conclusion: Higher FBG level was correlated with both higher mortality and proportion of evacuation of intracranial hematoma.
CITATION STYLE
Li, G., Wang, S., Xiong, Y., Gu, H., Jiang, Y., Yang, X., … Zhao, X. (2022). Higher fasting blood glucose was associated with worse in-hospital clinical outcomes in patients with primary intracerebral hemorrhage: From a large-scale nationwide longitudinal registry. CNS Neuroscience and Therapeutics, 28(12), 2260–2267. https://doi.org/10.1111/cns.13972
Mendeley helps you to discover research relevant for your work.